Aerosolized Agents - metered-dose inhalers: anti-inflammatory drugs

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.

  • Revision history
    • April 23, 2021; March 2019; March 2017; November 2015; March 2014; August 2012; June 2012; August 2010; July 2010; July 2007; February 2003; January 2002; January 2001; March 2000; January 2000; February 1999; March 1998; August 1997; February 1997
  • Initially developed
    • January 1995